Innovating Works

RUGUI BRIGHTS S.L.U

Activa
NanoSCAN: Developing multi modality nanomedicines for targeted annotation of oncogenic signaling pathways UNIVERSITAT ZURICH tramitó un H2020: ERC-2015-STG Spatial and temporal changes in the underlying biochemistry of cancer control disease progression and response/resistance to treatment. Deve...
2016-05-25 - 2022-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.